Light-Activated gel shows promise against rare skin cancer
NCT ID NCT06470451
First seen Nov 17, 2025 · Last updated May 11, 2026 · Updated 29 times
Summary
This study tests a gel called HyBryte, which is activated by visible light, to treat a rare type of skin lymphoma (CTCL). About 80 adults with early-stage disease will apply the gel to their skin lesions and then receive light treatment. The goal is to see if the gel can shrink or clear the lesions better than a placebo gel.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUTANEOUS T-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Accellacare (PMG)
COMPLETEDWilmington, North Carolina, 28411, United States
-
Austin Institute for Clinical Research
RECRUITINGPflugerville, Texas, 78660, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Columbia University Medical Center
COMPLETEDNew York, New York, 10032, United States
-
Dawes Fretzin Dermatology Group
RECRUITINGIndianapolis, Indiana, 46256, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospital of the University of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Inova Schar Cancer Institute
RECRUITINGFairfax, Virginia, 22031, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
MD Anderson
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
Contact
-
Mayo Clinic
RECRUITINGScottsdale, Arizona, 85259, United States
Contact
Contact Phone: •••-•••-••••
-
Medical Dermatology Specialists
COMPLETEDPhoenix, Arizona, 85006, United States
-
Northwestern University
RECRUITINGChicago, Illinois, 60611, United States
Contact Email: •••••@•••••
-
Penn State Health Hershey Medical Center
RECRUITINGHershey, Pennsylvania, 17033, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Rochester Skin Lymphoma Medical Group
RECRUITINGFairport, New York, 14450, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Therapeutics Clinical Research
COMPLETEDSan Diego, California, 92123, United States
-
University of Pittsburgh Medical Center
RECRUITINGPittsburgh, Pennsylvania, 15213, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of South Florida
RECRUITINGTampa, Florida, 33612, United States
-
Vanderbilt University
COMPLETEDNashville, Tennessee, 37212, United States
-
Washington University
RECRUITINGSt Louis, Missouri, 63110, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.